Feasibility of an Early Palliative Care Intervention for Metastatic Cancer Patients. A Phase 2 Study

August 13, 2014

Primary Outcome Measure:

Percentage of cancer patients that accept and attend the early palliative care programme [ Time Frame: up to 30 days after the diagnosis of cancer ] [ Designated as safety issue: No ]
Percentage of eligible cancer patients that accept the proposal of the intervention (the early palliative care programme) and that, by 30 days after the diagnosis, effectively start to be followed by the Palliative Care Unit

Secondary Outcome Measures:

Percentage of cancer patients that receive the proposal of early palliative by the oncologists-pneumologists [ Time Frame: up to 30 days after the diagnosis of cancer ] [ Designated as safety issue: No ]
Percentage of newly diagnosed eligible cancer patients that receive the proposal of the itegrated early palliative care programme

Eligibility Criteria

Inclusion Criteria:
Patients within 8 weeks of cancer diagnosis confirmed by histology or cytology Lung cancer (NSCLC or SCLC) stage IIIb-IV OR mesothelioma stage III-IV OR pancreas cancer stage IV, OR gastric cancer stage IIIb-IV Age more than 18 years Performance status (ECOG) ≤ 2; Ability to read, understand and fill-in the questionnaires Written informed consent to the study
Exclusion Criteria:
Any chemotherapy, radiotherapy or ormonotherapy for any tumour in the past 12 months

CONTACT INFORMATION

Name*

First Last

Email*

Phone*

Address*

Street Address Address Line 2 City State / Province / Region ZIP / Postal Code Country

Have you received a diagnosis?*

Yes

DIAGNOSIS

Diagnosis?*

Date of Diagnosis*

Comments*

This field is for validation purposes and should be left unchanged.

Quick Facts

Accepts Healthy Volunteers
Ages Available for Study
ClinicalTrials.gov Identifier
Collaborators
Contacts(s)
Location(s)
Estimated Enrollment
Estimated Study Start Date
Estimated Primary Completion Dates
Full Title
Genders Eligible for Study
Investigator(s)
Last Updated
Other Contact